The impact of zoledronic acid therapy in survival of bladder cancer patients with bone metastasis.

e15096 Background: Bone metastases occur in almost 40% of patients with bladder cancer. M-VAC chemotherapy to bone metastasis has been done and median survival time is 10 months. (Bajorin, JCO 17, ...